IVF_INSPIRE IVF
Inspire IVF Public Company Limited operates an infertility treatment center in Thailand. The company offers intrauterine insemination, preimplantation genetic testing, intracytoplasmic sperm injection, embryo transfer, fertility preservation, preventive and regenerative medicine, health checkup, and other infertility treatments. It provides obstetrics and gynecology examinations, consulting, and … Read more
IVF_INSPIRE IVF (IVF) - Net Assets
Latest net assets as of September 2024: ฿173.90 Million THB
Based on the latest financial reports, IVF_INSPIRE IVF (IVF) has net assets worth ฿173.90 Million THB as of September 2024.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (฿258.27 Million) and total liabilities (฿84.37 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ฿173.90 Million |
| % of Total Assets | 67.33% |
| Annual Growth Rate | 95.84% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 96.47 |
IVF_INSPIRE IVF - Net Assets Trend (2021–2023)
This chart illustrates how IVF_INSPIRE IVF's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for IVF_INSPIRE IVF (2021–2023)
The table below shows the annual net assets of IVF_INSPIRE IVF from 2021 to 2023.
| Year | Net Assets | Change |
|---|---|---|
| 2023-12-31 | ฿177.33 Million | +214.69% |
| 2022-12-31 | ฿56.35 Million | +21.76% |
| 2021-12-31 | ฿46.28 Million | -- |
Equity Component Analysis
This analysis shows how different components contribute to IVF_INSPIRE IVF's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 7240000000.0% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2023)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | ฿21.18 Million | 11.94% |
| Other Components | ฿156.15 Million | 88.06% |
| Total Equity | ฿177.33 Million | 100.00% |
IVF_INSPIRE IVF Competitors by Market Cap
The table below lists competitors of IVF_INSPIRE IVF ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
New England Realty Associates LP
NYSE MKT:NEN
|
$4.03 Million |
|
Ilyda SA
AT:ILYDA
|
$4.03 Million |
|
Constellation Resources Ltd
AU:CR1
|
$4.03 Million |
|
INTUITIVE SURGICAL (IUI1.SG)
STU:IUI1
|
$4.03 Million |
|
NEP Realty and Industry Public Company Limited
BK:NEP
|
$4.02 Million |
|
Pharma-Bio Serv Inc
OTCQB:PBSV
|
$4.02 Million |
|
Kohinoor Foods Limited
NSE:KOHINOOR
|
$4.02 Million |
|
Standard Industries Limited
NSE:SIL
|
$4.02 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in IVF_INSPIRE IVF's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2022 to 2023, total equity changed from 56,350,000 to 177,330,000, a change of 120,980,000 (214.7%).
- Net income of 40,990,000 contributed positively to equity growth.
- Other factors increased equity by 79,990,000.
Equity Change Factors (2022 to 2023)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ฿40.99 Million | +23.12% |
| Other Changes | ฿79.99 Million | +45.11% |
| Total Change | ฿- | 214.69% |
Book Value vs Market Value Analysis
This analysis compares IVF_INSPIRE IVF's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 1.79x
- The company is trading above its book value, indicating the market recognizes value beyond its reported assets.
- The price-to-book ratio has decreased from 6.85x to 1.79x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2021-12-31 | ฿0.11 | ฿0.72 | x |
| 2022-12-31 | ฿0.13 | ฿0.72 | x |
| 2023-12-31 | ฿0.40 | ฿0.72 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently IVF_INSPIRE IVF utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 23.12%
- The company demonstrates strong efficiency in generating profits from shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 33.72%
- • Asset Turnover: 0.47x
- • Equity Multiplier: 1.47x
- Recent ROE (23.12%) is above the historical average (9.95%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2021 | -11.11% | -45.73% | 0.08x | 3.05x | ฿-9.77 Million |
| 2022 | 17.83% | 15.87% | 0.42x | 2.69x | ฿4.42 Million |
| 2023 | 23.12% | 33.72% | 0.47x | 1.47x | ฿23.26 Million |
Industry Comparison
This section compares IVF_INSPIRE IVF's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $2,892,225,945
- Average return on equity (ROE) among peers: 25.66%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| IVF_INSPIRE IVF (IVF) | ฿173.90 Million | -11.11% | 0.49x | $4.03 Million |
| Aikchol Hospital Public Company Limited (AHC) | $1.55 Billion | 9.07% | 0.19x | $29.59 Million |
| Bangkok Chain Hospital Public Company Limited (BCH-R) | $6.40 Billion | 17.03% | 0.97x | $429.99 Million |
| Bumrungrad Hospital PCL (BH) | $13.10 Billion | 26.23% | 0.63x | $3.50 Billion |
| Chularat Hospital Public Company Limited (CHG) | $1.12 Billion | 29.84% | 0.38x | $205.50 Million |
| Chiang Mai Ram Medical Business Public Company Limited (CMR) | $5.27 Billion | 8.36% | 0.67x | $21.67 Million |
| Dental Corporation Public Company Limited (D) | $106.33 Million | 39.99% | 1.05x | $9.07 Million |
| Ekachai Medical Care Public Company Limited (EKH) | $953.94 Million | 16.80% | 0.15x | $56.66 Million |
| Genesis Fertility Center Public Company Limited (GFC) | $123.73 Million | 56.28% | 0.53x | $4.77 Million |
| Mukdahan International Hospital Public Company Limited (HANN) | $176.84 Million | 15.70% | 0.95x | $5.00 Million |
| Intermedical Care and Lab Hospital Public Company Limited (IMH) | $123.08 Million | 37.33% | 0.31x | $7.20 Million |